Cystatin C and Muscle Mass in Patients With Heart Failure

Juan B Ivey-Miranda1, Lesley A Inker2, Matthew Griffin3

  • 1Department of Heart Failure, Hospital de Cardiologia, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico; Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.

Insights

Estimated glomerular filtration rate (eGFR) from cystatin C may be inaccurate in heart failure (HF) patients due to muscle mass variations. Both cystatin C and creatinine-based eGFR require cautious interpretation in HF with body composition changes.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Biochemistry

Background:

  • Heart failure (HF) and sarcopenia are associated with altered body composition.
  • Creatinine-based estimated glomerular filtration rate (eGFRcr) accuracy is affected by muscle mass.
  • Cystatin C-based eGFR (eGFRcys) is hypothesized to be less influenced by muscle mass.

Purpose of the Study:

  • To assess the association between muscle mass and cystatin C levels.
  • To evaluate the accuracy of eGFRcys compared to eGFRcr.
  • To determine the association of eGFRcys with mortality in relation to muscle mass.

Main Methods:

  • Included 293 patients admitted with heart failure.
  • Muscle mass estimated using a creatinine excretion-based equation.
  • Compared accuracy of eGFRcys and eGFRcr against measured creatinine clearance.

Main Results:

  • Both cystatin C and creatinine levels increased significantly with higher muscle mass (P < .001).
  • eGFRcys and eGFRcr overestimated measured creatinine clearance in individuals with lower muscle mass.
  • eGFRcys underestimated measured creatinine clearance in individuals with higher muscle mass; eGFRcr did not.
  • Neither eGFRcys nor eGFRcr showed association with mortality after adjusting for muscle mass (P > .19).

Conclusions:

  • Cystatin C levels are associated with muscle mass in HF patients, potentially impacting eGFRcys accuracy.
  • eGFRcys, similar to eGFRcr, may not provide reliable GFR estimations in HF patients with common body composition abnormalities.
  • Results for eGFRcys in HF patients should be interpreted with caution due to muscle mass influence.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
244
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
554
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
189
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
16.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
588